CH501647A - Verfahren zur Herstellung von Piperazinderivaten - Google Patents

Verfahren zur Herstellung von Piperazinderivaten

Info

Publication number
CH501647A
CH501647A CH353167A CH353167A CH501647A CH 501647 A CH501647 A CH 501647A CH 353167 A CH353167 A CH 353167A CH 353167 A CH353167 A CH 353167A CH 501647 A CH501647 A CH 501647A
Authority
CH
Switzerland
Prior art keywords
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
CH353167A
Other languages
German (de)
English (en)
Inventor
Jacob Van Der Burg Willem
Delobelle Jacques
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of CH501647A publication Critical patent/CH501647A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH353167A 1966-03-12 1967-03-10 Verfahren zur Herstellung von Piperazinderivaten CH501647A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (Direct) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
CH501647A true CH501647A (de) 1971-01-15

Family

ID=19795968

Family Applications (1)

Application Number Title Priority Date Filing Date
CH353167A CH501647A (de) 1966-03-12 1967-03-10 Verfahren zur Herstellung von Piperazinderivaten

Country Status (13)

Country Link
US (1) US3534041A (Direct)
BE (1) BE695304A (Direct)
BR (1) BR6787719D0 (Direct)
CH (1) CH501647A (Direct)
DE (2) DE1695556C3 (Direct)
DK (1) DK124824B (Direct)
ES (1) ES337526A1 (Direct)
FI (1) FI51694C (Direct)
FR (1) FR6764M (Direct)
GB (1) GB1173783A (Direct)
GR (1) GR37262B (Direct)
NL (2) NL6603256A (Direct)
SE (1) SE331999B (Direct)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
GB2091247B (en) * 1980-12-31 1984-07-18 Beecham Group Ltd Pentacyclic compounds processes for their preparation and their use
EP0088575B1 (en) * 1982-03-05 1986-12-30 Beecham Group Plc Pentacyclic compounds
EP0090552A3 (en) * 1982-03-27 1984-04-25 Beecham Group Plc Pentacyclic compounds
EP0126343A1 (en) * 1983-05-18 1984-11-28 Beecham Group Plc Treatment of diarrhoea
EP0134984B1 (en) * 1983-07-16 1988-07-13 Beecham Group Plc Benzazepine and benzoxazepine derivatives
ATE188217T1 (de) * 1987-04-10 2000-01-15 Univ Monash 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
ATE112491T1 (de) 1990-09-13 1994-10-15 Akzo Nobel Nv Stabilisierte feste chemische zusammensetzungen.
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1017695A4 (en) * 1997-09-26 2002-01-16 Univ Monash RESOLUTION OF OPTICALLY ACTIVE COMPOUNDS
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
NZ545494A (en) 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
CN102633730A (zh) 2004-12-03 2012-08-15 先灵公司 作为cb1拮抗剂的取代哌嗪
EP1904843A2 (en) 2005-07-08 2008-04-02 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
NZ569814A (en) 2006-01-18 2011-10-28 Schering Corp Cannibinoid receptor modulators
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US8623873B2 (en) 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
GB1173783A (en) 1969-12-10
DE1695556B2 (de) 1980-10-30
FI51694B (Direct) 1976-11-30
NL129434C (Direct)
NL6603256A (Direct) 1967-09-13
DK124824B (da) 1972-11-27
DE1695556C3 (de) 1981-06-25
DE1695556A1 (de) 1972-01-20
US3534041A (en) 1970-10-13
BR6787719D0 (pt) 1973-12-26
DE1795836C2 (de) 1978-07-20
ES337526A1 (es) 1968-03-01
DE1795836B1 (de) 1977-11-24
BE695304A (Direct) 1967-09-11
FR6764M (Direct) 1969-03-10
GR37262B (el) 1969-05-10
FI51694C (fi) 1977-03-10
SE331999B (Direct) 1971-01-25

Similar Documents

Publication Publication Date Title
CH501647A (de) Verfahren zur Herstellung von Piperazinderivaten
CH492676A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanol-Derivaten
CH504452A (de) Verfahren zur Herstellung von Morpholinderivaten
CH471141A (de) Verfahren zur Herstellung von Pyrazinderivaten
AT303955B (de) Verfahren zur Herstellung von Cephalosporinderivaten
CH491119A (de) Verfahren zur Herstellung von N6-Aralkyl-adenosin-derivaten
CH489517A (de) Verfahren zur Herstellung von N-Acylsydnoniminderivaten
CH460020A (de) Verfahren zur Herstellung von Piperazinderivaten
CH513911A (de) Verfahren zur Herstellung von Piperazinderivaten
CH494206A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH493465A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH520741A (de) Verfahren zur Herstellung von Anthrachinonderivaten
CH510640A (de) Verfahren zur Herstellung von Diarylcyclopropan-Derivaten
AT273953B (de) Verfahren zur Herstellung von v-Triazolyl-cumarinderivaten
CH496005A (de) Verfahren zur Herstellung von Piperazin-Derivaten
CH486485A (de) Verfahren zur Herstellung von Dibenzothiazinderivaten
CH457452A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH489509A (de) Verfahren zur Herstellung von Derivaten des Piperazins
CH458362A (de) Verfahren zur Herstellung von Piperazinderivaten
CH480317A (de) Verfahren zur Herstellung von 16-Methylen-19-nor-progesteron-derivaten
CH521358A (de) Verfahren zur Herstellung von Phenazinderivaten
CH496663A (de) Verfahren zur Herstellung von 2-Benzyliden-cyclopentanonderivaten
CH458370A (de) Verfahren zur Herstellung von Imidazolidinonsulfonamidderivaten
CH444165A (de) Verfahren zur Herstellung von Piperazinderivaten
CH494225A (de) Verfahren zur Herstellung von Chinolinderivaten

Legal Events

Date Code Title Description
PL Patent ceased